In the context of this research work, we studied the problem of privacy preserving on spatiotemporal databases. In particular, we investigated the k-anonymity of mobile users based on real trajectory data. The k-anonymity set consists of the k nearest neighbors. We constructed a motion vector of the form (x,y,g,v) where x and y are the spatial coordinates, g is the angle direction, and v is the velocity of mobile users, and studied the problem in four-dimensional space. We followed two approaches. The former applied only k-Nearest Neighbor (k-NN) algorithm on the whole dataset, while the latter combined trajectory clustering, based on K-means, with k-NN. Actually, it applied k-NN inside a cluster of mobile users with similar motion pattern (g,v). We defined a metric, called vulnerability, that measures the rate at which k-NNs are varying. This metric varies from 1 k (high robustness) to 1 (low robustness) and represents the probability the real identity of a mobile user being discovered from a potential attacker. The aim of this work was to prove that, with high probability, the above rate tends to a number very close to 1 k in clustering method, which means that the k-anonymity is highly preserved. Through experiments on real spatial datasets, we evaluated the anonymity robustness, the so-called vulnerability, of the proposed method.
Drug resistance in chronic myelogenous leukemia (CML) requires the development of new CML chemotherapeutic drugs. Indirubin, a well-known mutikinase inhibitor, is the major active component of "Danggui Longhui Wan", a Chinese traditional medicine used for the treatment of CML symptoms. An in-house collection of indirubin derivatives was screened at 1 μM on wild-type and imatinib-resistant T315I mutant CML cells. Herein are reported that only 15 analogues of the natural 6-bromoindirubin displayed potent cytotoxicity in the submicromolar range. Kinase assays in vitro show that eight out of the 15 active molecules strongly inhibited both c-Src and Abl oncogenic kinases in the nanomolar range. Most importantly, these eight molecules blocked the activity of T315I mutant Abl kinase at the submicromolar level and with analogue 22 exhibiting inhibitory activity at the low nanomolar range. Docking calculations suggested that active indirubins might inhibit T315I Abl kinase through an unprecedented binding to both active and Src-like inactive conformations. Analogue 22 is the first derivative of a natural product identified as an inhibitor of wild-type and imatinib-resistant T315I mutant Abl kinases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.